Consecutive severe immune-related adverse events after PD-1 inhibitor induction and surgery in locally advanced non-small cell lung cancer: a case report.

Zhao, Hang; Ning, Junwei; Gu, Yu; Zhang, Xiaocheng; Yu, Wen; Chen, Tianxiang; Luo, Qingquan

Zhao, Hang; Ning, Junwei; Gu, Yu; Zhang, Xiaocheng; Yu, Wen; Chen, Tianxiang; Luo, Qingquan.

Afiliación

Zhao H; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Ning J; Thoracic Surgery Department, Dongyang People's Hospital, Dongyang, China.
Gu Y; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhang X; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yu W; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Chen T; Department of Pulmonary Medicine, Ruian People's Hospital, Wenzhou, China.
Luo Q; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

Transl Lung Cancer Res ; 10(8): 3682-3688, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34584866

Palabras clave

Hepatitis; case report; immune-related adverse events (irAEs); non-small cell lung cancer (NSCLC); pneumonia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Transl Lung Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google